Minimally-invasive gene delivery of a novel inhibitor of retinal angiogenesis [ 2014 - 2016 ]

Research Grant

Researchers: Prof Gregory Dusting (Principal investigator) ,  A/Pr Bang Bui ,  Dr Guei-Sheung Liu ,  Dr Hong Zhang ,  Prof Tien Wong

Brief description Excessive growth of blood vessels in the eye causes vision loss and can only be treated with lasers or painful and frequent injections into the eye. Vasostatin is a specific inhibitor of angiogenesis and a promising agent for the management of ocular neovascularisation. We will provide pre-clinical evidence that gene delivery of vasostatin-like peptides is an effective therapeutic strategy and it has potential to revolutionize the current ophthalmic care of age-related macular degeneration.

Funding Amount $AUD 883,883.39

Funding Scheme Project Grants

Notes Standard Project Grant